论文标题
Cardioxnet:使用心脏声记录的心血管疾病分类的新型轻量级深度学习框架
CardioXNet: A Novel Lightweight Deep Learning Framework for Cardiovascular Disease Classification Using Heart Sound Recordings
论文作者
论文摘要
令人震惊的高死亡率和心血管疾病的全球流行率的增加表明对早期检测方案的关键需求。由于其简单性和成本效益,在该域中,PhonCardiogram(PCG)信号已在该域中使用。在本文中,我们提出了Cardioxnet,这是一种新型的轻质端到端CRNN结构,用于自动检测五类心脏听觉,即使用RAW PCG信号,即正常,主动脉狭窄,二尖瓣狭窄,二尖瓣狭窄,二尖瓣膨胀和二尖瓣脱垂。两个学习阶段的参与使该过程自动化。在表示学习阶段已经实现了三个平行的CNN途径,以从PCG中学习粗糙和细粒度的特征,并探索涉及2D-CNN基于2D-CNN的可变接收场的显着特征。因此,在表示学习阶段,网络提取有效的时间不变特征,并以极快的速度收敛。在顺序残留学习阶段,具有双向LSTM和跳过连接,网络可以熟练提取时间特征,而无需在信号上执行任何特征提取。获得的结果表明,与先前的最新方法相比,所提出的端到端体系结构在所有评估指标中均能产生出色的性能,其精度高达99.60%,精度为99.56%,召回率为99.52%和99.68%的召回率和99.68%的F1-在计算上平均得分。该模型的表现优于先前的作品,使用相同的数据集以相当大的余量为单位。主要数据集和次要数据集上的高精度指标与参数数量明显较少,并且端到端的预测方法使所提出的网络适用于使用内存约束移动设备在低资源设置中进行护理点CVD筛选。
The alarmingly high mortality rate and increasing global prevalence of cardiovascular diseases signify the crucial need for early detection schemes. Phonocardiogram (PCG) signals have been historically applied in this domain owing to its simplicity and cost-effectiveness. In this paper, we propose CardioXNet, a novel lightweight end-to-end CRNN architecture for automatic detection of five classes of cardiac auscultation namely normal, aortic stenosis, mitral stenosis, mitral regurgitation and mitral valve prolapse using raw PCG signal. The process has been automated by the involvement of two learning phases. Three parallel CNN pathways have been implemented in the representation learning phase to learn the coarse and fine-grained features from the PCG and to explore the salient features from variable receptive fields involving 2D-CNN based squeeze-expansion. Thus, in the representation learning phase, the network extracts efficient time-invariant features and converges with great rapidity. In the sequential residual learning phase, with the bidirectional-LSTMs and the skip connection, the network can proficiently extract temporal features without performing any feature extraction on the signal. The obtained results demonstrate that the proposed end-to-end architecture yields outstanding performance in all the evaluation metrics compared to the previous state-of-the-art methods with up to 99.60% accuracy, 99.56% precision, 99.52% recall and 99.68% F1- score on an average while being computationally comparable. This model outperforms the previous works using the same dataset by a considerable margin. The high accuracy metrics on both primary and secondary dataset combined with a significantly low number of parameters and end-to-end prediction approach makes the proposed network suitable for point of care CVD screening in low resource setups using memory constraint mobile devices.